Recent advances in hepatitis research have shed new light on the etiology, pathogenesis, epidemiology and prevention of type B hepatitis infection. The so-called 'Dane' particle is probably the complete hepatitis B virion; its outer coat is the hepatitis B (Australia) antigen (HB Ag) and its inner core is an immunologically distinct particle. Subtypes of HB Ag (a, d, y, w and r) are useful indices for epidemiological surveys. Concepts of epidemiology have changed: type B hepatitis is transmissible by contact as well as by inoculation. The presence of HB Ag in blood is indicative of the presence of hepatitis B virus. Tests to detect antigen and use of voluntary blood donors have played a major role in the decreased incidence of post transfusion hepatitis. A special hepatitis B ganmaglobulin preparation and a heat-inactivated hepatitis B vaccine have proved to be effective in preliminary studies.
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THE term viral hepatitis refers to two immunologically distinct entities: type A (infectious) hepatitis and type B (serum) hepatitis. Viral hepatitis, type A is an ancient disease which was described by Hippocrates as an 'infectious icterus' more than 2000 years ago. In contrast, type B hepatitis has a more recent history since the first outbreak was recognized in 1883, less than 100 years ago (Lurman, 1885) .
Evidence for the viral etiology of hepatitis stems in great part from investigations by MacCallum and Bradley in the United Kingdom (1944), Havens et al. (1944) , Paul et al. (1945) , and Neefe et al. (1945) in the United States in the early 1940s. They identified the two immunologically distinct types of hepatitis which were designated type A and type B. These observations were extended by Murray et al. (1955) in the early 1950s and by our group in the late 1950s and 1960s (Ward et al., 1958; Krugman et al., 1959 Krugman et al., , 1962 Krugman et al., , 1967 .
Our studies were conducted in a large institution for mentally retarded residents where hepatitis was highly endemic. During the course of these studies we had an opportunity to observe patients with hepatitis from the time of exposure, during the incubation period, after onset of jaundice or abnormal serum transaminase activity, and for many years thereafter. The serial samples of serum which were obtained provided valuable materials for the characterization of the clinical, epidemiological and immunological aspects of the infection. The background of this investigation is described in detail in previous publications (Krugman et al., 1959 (Krugman et al., , 1962 (Krugman et al., , 1967 (Krugman et al., , 1970 .
In the mid 1960s it became obvious that two types of hepatitis were endemic in the institution. One type, designated MS-1, resembled typical viral hepatitis, type A; it had a relatively short incubation period. The other type, MS-2, was associated with a longer incubation period and it resembled viral hepatitis, type B. It was observed that in this long incubation period, hepatitis infection was transmissible by mouth and by contact as well as by inoculation. The differential features of MS-1 and MS-2 types of hepatitis are shown in Fig. 1 and Table 1 .
The discovery of Australia antigen (Blumberg et al., 1965) and its association with hepatitis B virus infection (Prince, 1968; Krugman et al., 1970) LeBouvier (1971 LeBouvier ( , 1972 . He and other workers have observed a common group specificity for the antigen which has been designated 'a', and two mutually exclusive subspecificities, 'd' and 'y'. Two additional determinants, 'w' and 'r' were described by Bancroft, Mundon and Russell (1972 23 Fig. 2 ). In general, HB Ag persisted for several days or weeks after subsidence of jaundice (patients no. 4, 8, 10, 11, 12 and 13, Fig. 3 ). However, in some instances the jaundice persisted longer than the antigen (patients no. 3, 5, 7 and 9, Fig. 2 ). (Szmuness et al., 1973) . Regional variations have been observed, the lowest incidence being in the North Central States (0-06%) and the highest in the South-eastern States (0-17%) and Puerto Rico (0-34%). In contrast with these observations, the incidence of HB Ag-positive blood obtained from paid commercial donors was approximately ten times higher (Cherubin and Prince, 1971) .
The high incidence of HB Ag in blood obtained from paid donors confirmed past experience indicating that the use of blood from this source was associated with a high incidence of post-transfusion hepatitis. These findings provided an added stimulus to increase the voluntary donations of blood. A prospective study by Alter et al. (1972) Gocke and Panick (1972) and by Caggiano (1972) indicated that the transfusion of HB Ab-positive blood was not associated with an increased risk of post-transfusion hepatitis.
To date, the routine screening of blood for the presence of HB Ag has played an important role in the control of post-transfusion hepatitis. The (Krugman et al., 1971) and by Soulier et al. (1972) (Krugman et al., 1971a, b) and Soulier et al. (1972) . Serum containing our MS-2 strain of HBV was diluted in distilled water and heated for 1 min at 98°C. The heat-treated serum proved to be antigenic and non-infectious. The results of active immunization of twenty-nine children were summarized in a recent report . The data are shown in Figs. 4 and 5. As indicated in Fig. 4 a parenteral inoculation of unheated MS-2 serum was followed by antigenemia in all twenty-five unimmunized children; abnormal SGOT values were observed in twenty-four members of this group. In contrast, of twenty-nine children who received one to three inoculations of heatinactivated MS-2 serum, 4-8 months before a parenteral exposure to unheated MS-2 serum, nineteen (65 %) were protected (Fig. 5) 
